Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Neurology | Musculoskeletal | Family Medicine
Disease Category: Fibromyalgia
Location: United States, OK
Clinical Trial Details
Research Study Summary
A Study for the Treatment of Subjects with Fibromyalgia
This trial's participation duration is 21 weeks where
subjects will be seen in the clinic for a total of 12 visits.
Primary outcome is for a decrease in pain from fibromyalgia due to
the study drug.
Patient Inclusion Criteria
- Male or female subject must be 18 years of age or older and
meets the ACR criteria for fibromyalgia.
- Other inclusion criteria apply
Patient Exclusion Criteria
- Subject has Major Depressive Disorder, Bipolar, or other
psychotic disorder and cannot safely discontinue use of
- Subject has Rheumatic disease in addition to fibromyalgia or
other painful conditions that would interfere with the ability to
measure change on any outcome measures associated with stiffness
and muscle weakness.
- Other exclusion criteria apply
Qualified participants will receive, at not charge, study
medication, study-related medical care, and laboratory
If you are interested in this, or any other studies we currently
have enrolling, please contact us for further information.
To Learn more
Both Male and Female
Date Last Changed:
July 25, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.